What does EPIMELIA do?

EPIMELIA is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”. Also registered: commercial agency. Public Limited, started on 7 November 2017, 1 establishment.

What is the address of EPIMELIA?

The registered office of EPIMELIA is located at Avenue Georges Lemaitre 19, 6041 Charleroi.

Is EPIMELIA still active?

Yes. According to the CBE (31 October 2026) EPIMELIA is active, legal situation “Normale toestand”, started on 7 November 2017.

Is EPIMELIA registered on Peppol?

Yes, EPIMELIA is registered on the Peppol network with ID 0208:0684478817.

What is the enterprise number of EPIMELIA?

The enterprise number of EPIMELIA is BE0684478817.

When was EPIMELIA founded?

EPIMELIA was founded on 7 November 2017.

Who are the directors of EPIMELIA?

According to the 2025 annual accounts, the directors of EPIMELIA are: BIOLINE AGROSCIENCES GROUP, NENUPHAR VERT.

Is EPIMELIA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 November 2017; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did EPIMELIA make in 2025?

EPIMELIA posted a profit after taxes of € 5,243 in financial year 2025.

What is the revenue of EPIMELIA?

As a small company, EPIMELIA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 32,978.

EPIMELIA (Public Limited) - Charleroi - BE0684478817

Dossier EPIMELIA, printed on 1 November 2026 from databakkes.be/en/0684478817/epimelia. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

EPIMELIA from Charleroi, company number BE0684478817, closed financial year 2025 with a result of € 5,243 after tax. For that financial year EPIMELIA recorded a gross margin of € 32,978 and equity of € 197,382. Compared with financial year 2024, the result moved from € 24,604 to € 5,243. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 15, 2026.

What it is worth Growing

€ 197,382

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 5,243

▼ 79% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 173,471

▲ 22% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 135,882.

People and assets in 2025

Vehicles and equipment

€ 5,676

▼ 25% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 62,854

▲ 198% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,026

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 115,738 Gross margin 2022: € 115,738 First fiscal year in the series	€ 60,318 Gross margin 2023: € 60,318 ▼ 48% vs 2022 (€ 115,738) Unfavourable step	€ 73,060 Gross margin 2024: € 73,060 ▲ 21% vs 2023 (€ 60,318) Favourable step	€ 32,978 Gross margin 2025: € 32,978 ▼ 55% vs 2024 (€ 73,060) Unfavourable step	▼ 55%
Profit after taxes	€ 54,296 Profit after taxes 2022: € 54,296 First fiscal year in the series	€ -2,790 Profit after taxes 2023: € -2,790 ▼ € 57,087 vs 2022 (€ 54,296) Unfavourable step	€ 24,604 Profit after taxes 2024: € 24,604 ▲ € 27,395 vs 2023 (€ -2,790) Favourable step	€ 5,243 Profit after taxes 2025: € 5,243 ▼ 79% vs 2024 (€ 24,604) Unfavourable step	▼ 79%
Equity	€ 170,325 Equity 2022: € 170,325 First fiscal year in the series	€ 167,534 Equity 2023: € 167,534 ▼ 2% vs 2022 (€ 170,325) Unfavourable step	€ 192,139 Equity 2024: € 192,139 ▲ 15% vs 2023 (€ 167,534) Favourable step	€ 197,382 Equity 2025: € 197,382 ▲ 3% vs 2024 (€ 192,139) Favourable step	▲ 3%
Total debts	€ 675,208 Total debts 2022: € 675,208 First fiscal year in the series	€ 608,252 Total debts 2023: € 608,252 ▼ 10% vs 2022 (€ 675,208) Favourable step	€ 536,107 Total debts 2024: € 536,107 ▼ 12% vs 2023 (€ 608,252) Favourable step	€ 317,880 Total debts 2025: € 317,880 ▼ 41% vs 2024 (€ 536,107) Favourable step	▼ 41%
Cash	€ 332,489 Cash 2022: € 332,489 First fiscal year in the series	€ 250,996 Cash 2023: € 250,996 ▼ 25% vs 2022 (€ 332,489) Unfavourable step	€ 141,698 Cash 2024: € 141,698 ▼ 44% vs 2023 (€ 250,996) Unfavourable step	€ 173,471 Cash 2025: € 173,471 ▲ 22% vs 2024 (€ 141,698) Favourable step	▲ 22%
Retained profit	€ 108,825 Retained profit 2022: € 108,825 First fiscal year in the series	€ 106,034 Retained profit 2023: € 106,034 ▼ 3% vs 2022 (€ 108,825) Unfavourable step	€ 130,639 Retained profit 2024: € 130,639 ▲ 23% vs 2023 (€ 106,034) Favourable step	€ 135,882 Retained profit 2025: € 135,882 ▲ 4% vs 2024 (€ 130,639) Favourable step	▲ 4%
Bank debt	€ 500,000 Bank debt 2022: € 500,000 First fiscal year in the series	€ 500,000 Bank debt 2023: € 500,000 Unchanged (€ 500,000) Unchanged	€ 500,000 Bank debt 2024: € 500,000 Unchanged (€ 500,000) Unchanged	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 500,000) Favourable step	▼ 100%
Balance sheet total	€ 845,533 Balance sheet total 2022: € 845,533 First fiscal year in the series	€ 775,786 Balance sheet total 2023: € 775,786 ▼ 8% vs 2022 (€ 845,533) Unchanged	€ 728,246 Balance sheet total 2024: € 728,246 ▼ 6% vs 2023 (€ 775,786) Unchanged	€ 515,262 Balance sheet total 2025: € 515,262 ▼ 29% vs 2024 (€ 728,246) Unchanged	▼ 29%

Key figures of EPIMELIA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to EPIMELIA?

What happened at EPIMELIA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2031 BIOLINE AGROSCIENCES GROUP stepped down as director. NBB
Oct 15, 2026 New annual accounts for financial year 2025: profit of € 5,243 (▼ 79% vs 2024). filed late Source: NBB ↗
2025 BIOLINE AGROSCIENCES GROUP became a director. NBB
2025 NENUPHAR VERT stepped down as director. NBB
2019 NENUPHAR VERT became a director. NBB
Nov 7, 2017 New establishment in Charleroi. KBO
Nov 7, 2017 Start of the company according to the CBE. KBO

In short

From € 54,296 profit in 2022 to € 5,243 profit in 2025.

Paid € 1,476 in corporate taxes since 2022.

Best year ever: 2022, with € 54,296 profit.

Original PDFs at the National Bank ↗

Management

Nénuphar Vert 95%

The stake of Nénuphar Vert comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

EPIMELIA

The shares are held by Nénuphar Vert (95%).

Directors

According to the 2025 annual accounts

BIOLINE AGROSCIENCES GROUP

Director · represented by Ludwik Pokorny

Also active at: ECJF, VIRIDAXIS

since 2025 · until 2031

NENUPHAR VERT

Director · represented by HARRIS Alison HARRIS Alison

Also active at: ECJF, KRISALIS, ALLIOR, VIRIDAXIS

since 2019 · until 2025

Shareholders

Nénuphar Vert

95%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue Georges Lemaitre 19

6041 Charleroi

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.

All companies at this address →

Union des Kinésithérapeutes de Belgique

SOCIETE D'ETUDE ET DE REFLEXION EN KINESITHERAPIE

Beautiful Landscape

€ -2,400 gross margin · 2025

Nénuphar Vert same network

€ 615,331 gross margin · 2025

NWIC

+2 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0684.478.817

VAT number

BE 0684.478.817

Registered office

Avenue Georges Lemaitre 19, 6041 Charleroi

Names & denominations

EPIMELIA

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

7 November 2017

Peppol

Active · Active since 8 Dec 2025

Activities · NACE

Overige zakelijke dienstverlening, neg

Handelsbemiddeling in de niet-gespecialiseerde groothandel

View on CBE Public ↗ Annual accounts (NBB) ↗

EPIMELIA

Financials

What happened to EPIMELIA?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions